Directory
>
Betty Mendes
Betty Mendes
VP Clinical Operations | Atara Biotherapeutics
Thousand Oaks, California, United States
Betty Mendes
Summary
Betty Mendes is a seasoned executive with over three decades of experience in clinical operations and drug development. Currently serving as the VP of Clinical Operations at Atara Biotherapeutics, she has a strong background in biostatistics, clinical trials, and regulatory affairs. Her career journey includes leadership roles at major pharmaceutical companies such as Amgen and Pfizer, where she has consistently driven process improvements and strategic initiatives. Betty holds a Master's degree in Health Care Management from UCLA and a Bachelor's degree in Applied Physiology from Boston University. She is passionate about advancing therapeutic areas like oncology and immunology, and is recognized for her expertise in navigating complex clinical landscapes. With a proven track record of success, Betty is dedicated to fostering innovation in life sciences and improving patient outcomes.
Betty Mendes
Work Experience
VP Clinical Operations at
Atara Biotherapeutics
January 2018 - Present
VP Clinical Operations at
Intercept Pharmaceuticals
January 2017 - January 2018
Executive Director, Clinical Operations at
FibroGen, Inc.
January 2016 - January 2017
Sr. Director, Clinical Operations at
Onyx Pharmaceuticals A Subsidiary Of Amgen
January 2014 - January 2015
Exec Dir, Global Study Mgmt at
Amgen, Inc.
January 2007 - January 2014
Therapeutic Area Operations Director at
Amgen, Inc.
January 2005 - January 2007
Associate Director, Medical Research, Medical Affairs at
Amgen, Inc.
January 2003 - January 2005
Clinical Study Management at
Amgen, Inc.
January 1999 - January 2003
Sr Clinical Research Associate at
Amgen, Inc.
January 1996 - January 1999
Clinical Research Associate at
Pfizer, Inc.
January 1991 - January 1996
Research Associate at
Memorial Hospital of RI
January 1989 - January 1991
Betty Mendes
Education
University of California, Los Angeles, Mph
January 2000 - January 2002
January 1985 - January 1989
Frequently Asked Questions about Betty Mendes
What is Betty Mendes email address?
Betty Mendes's primary email address is *******@atarabio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Betty Mendes work for?
Betty Mendes is a VP Clinical Operations at Atara Biotherapeutics, a company specializing in Commercial physical research.
Where Betty Mendes graduated from?
Betty Mendes holds a degree in Health Care Management from University of California, Los Angeles.
How can I directly contact Betty Mendes?
To contact Betty Mendes directly, you can use the email address *******@atarabio.com. Complete contact information is available upon registration with Muraena.
Who is Betty Mendes?
Betty Mendes is a seasoned executive with over three decades of experience in clinical operations and drug development. Currently serving as the VP of Clinical Operations at Atara Biotherapeutics, she has a strong background in biostatistics, clinical trials, and regulatory affairs. Her career journey includes leadership roles at major pharmaceutical companies such as Amgen and Pfizer, where she has consistently driven process improvements and strategic initiatives. Betty holds a Master's degree in Health Care Management from UCLA and a Bachelor's degree in Applied Physiology from Boston University. She is passionate about advancing therapeutic areas like oncology and immunology, and is recognized for her expertise in navigating complex clinical landscapes. With a proven track record of success, Betty is dedicated to fostering innovation in life sciences and improving patient outcomes.
Betty`s contact details
*******@atarabio.com
Colleagues
Chairman of the Board
Vice President, Head Of People
Chief People Officer
Chief Regulatory and Quality Officer
Chief Information Officer
Chief Medical Officer
Vice President Quality Operations
Chief Operating Officer and Chief Financial Officer
Vice President, Head of Global Value, Access and Outcomes
SVP, Platform Sciences